TGFB1 and neoplasm: In mouse model of bone metastases, it was first demonstrated by Yin et al. that blocking TGF-β signaling by stably transfecting a dominant negative TβRII (DNTβRII), in MDA-231 breast cancer cells, inhibited TGF-β-induced expression of PTHrP production in tumor cells.